JPRN-jRCT1061190014进行中（未招募）4 期
Immunogenicity and safety of quadrivalent meningococcal polysaccharide-protein conjugate vaccine among Japanese people aged >=56 years - MV 56 or older
Tanaka Takaaki0 个研究点目标入组 20 人开始时间: 2019年9月4日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 56age old 至 ot applicable（—）
- 性别
- All
入选标准
- •56 years old or older persons who wish to be immunized with meningococcal vaccine
排除标准
- •The persons listed below are excluded from study registration
- •manifest fever (37.5 degree or more temperature)
- •suffering from severe acute illness
- •history of hypersensitivity to the vaccine component
- •history of invasive meningococcal disease
- •other inappropriate conditions for vaccination
研究者
相似试验
已完成
不适用
Immunogenicity and safety of quadrivalent meningococcal polysaccharide-protein conjugate vaccine among Japanese people aged >=56 yearsmeningococcal diseaseJPRN-UMIN000022803Tokyo Medical University Hospital Travellers' Medical Center23
招募中
4 期
MENPI: Safety and immunogenicity following meningococcal and pneumococcal immunization among adult people living with HIV. A single center, non-blinded, randomized clinical trial2024-516961-35-01Hvidovre Hospital55
招募中
1 期
Meningococcal B vaccine in patients with aspleniaSplenectomyMedDRA version: 20.0Level: PTClassification code: 10041642Term: Splenectomy Class: 100000004865CTIS2023-508192-36-00Medical University of Vienna80
进行中（未招募）
不适用
Studies on evaluation of immunogenicity of meningococcal vaccine in KoreaCertain infectious and parasitic diseasesKCT0002460Ewha Womans University Medical Center90
已完成
3 期
Study of the Quadrivalent Influenza Vaccine in Participants 6 Months of Age and Older in IndiaCTRI/2021/11/037841Sanofi Healthcare India Private Limited SHIP400